Reduced cholesterol is associated with recent minor illness. The CARDIA Study

American Journal of Epidemiology

Volumn 146, Issue 7, 1997, Pages 558-564

  Jacobs Jr , David R ^a   Hebert, Brian ^b   Schreiner, Pamela J ^a   Sidney, Stephen ^c   Iribarren, Carlos ^a   Hulley, Stephen ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cold; Influenza; Lipids; Nausea; Smoking; Vomiting

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CORONARY ARTERY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INFLUENZA; LIPID METABOLISM; MAJOR CLINICAL STUDY; NAUSEA; RISK FACTOR; SELF REPORT; SMOKING HABIT; SYMPTOMATOLOGY; VOMITING;

EID: 2642607899     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009314     Document Type: Article

References (33)

1. Groen J, Tjiong BK, Kamminga CE, et al. The influence of nutrition, individuality and some other factors, including various forms of stress, on the serum cholesterol: an experiment of nine months duration in 60 normal human volunteers. Voeding 1952;13:556-87.
2. Beisel WR. Impact of infectious disease upon fat metabolism and immune functions. Cancer Res 1981;41:3797-8.
3. Beisel WR, Fiser RH. Lipid metabolism during infectious illness. Am J Clin Nutr 1970;23:1069-79.
4. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986;32:142-5.
5. Lees RS, Fiser RH, Beisel WR, et al. Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 1972;21:825-33.
6. Sammalkorpi K, Valtonen V, Kerttula Y, et al. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988;37:859-65.
7. Keller H. Postoperative Laboratoriumsuntersuchungen. (In German). (Postoperative laboratory investigations). Langenbecks Arch Chir 1973;334:631-9.
8. Wolfram G, Eckhart J, Zöllner N. Störungen des Lipoprotein-und Fettesaurenstoffwechsels bei Schwerverletzten. (In German). (Disturbances of lipoprotein and fatty acid metabolism in the severely injured). Klinische Wochenschrift 1980;58:1327-37.
9. Aufenanger J, Walter H, Katterman R. Untersuchungen zum Lipid-und Lipoproteinstoffwechsel beim Menschen nach operativen Eingriffen. (In German). (Investigations of lipid and lipoprotein metabolism in man after operative intervention). Langenbecks Arch Chir 1993;378:41-8.
10. Kesteloot H, Cobbaert C, Meyns B, et al. Time course of serum lipid and lipoprotein levels after coronary bypass surgery: modification by pravastatin. Acta Cardiol 1992;47:519-28.
11. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 1986;129:101-23.
12. Warnick GR, Benderson J, Albers JJ. Dextran sulphate-Mg+ precipitation procedure for quantification of high density lipoprotein cholesterol in plasma. Clin Chem 1982;28:1379-88.
13. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma. Clin Chem 1972;18:499-501.
14. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
15. Liu K, Slattery M, Jacobs DR, et al. A study of the reliability and comparative validity of the CARDIA dietary history. Ethn Dis 1994;4:15-27.
16. Jacobs DR, Hahn LP, Haskell WL, et al. Validity and reliability of a short physical activity history: CARDIA and the Minnesota Heart Health Program. J Cardiopulm Rehabil 1989;9:448-59.
17. Anderson JT, Jacobs DR, Foster N, et al. Scoring systems for evaluating dietary pattern effects on serum cholesterol. Prev Med 1979;8:525-37.
18. Griffith DE, Perkins RC. Changing strategies for treatment of chronic bronchitis. Semin Respir Infect 1994;9:49-57.
19. Green MS, Luz J, Gofer D. Absence from work among smokers and nonsmokers in Israeli industries - the CORDIS study. Isr J Med Sci 1992;28:645-9.
20. Shor-Posner G, Basil A, Ying L, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993;94:515-19.
21. Muga R, Tor J, Rey-Joly C, et al. Dislipemia e infección por VIH-1 en adictos a drogas intravenosas. (In Spanish). (Dyslipidemia and HIV-1 infection in intravenous drug addicts). Med Clin (Bare) 1993;100:161-3.
22. Grunfeld C, Pang M, Doerrler W, et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-52.
23. Feingold KR, Krauss RM, Pang M, et al. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 1993;76:1423-7.
24. Grunfeld C, Kotler DP, Shigenaga JK, et al. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991;90:154-62.
25. Malmendier CL, Amerijckx JP, Bihain BE, et al. Changes in apolipoprotein and lipids in patients after surgery. Biomed Pharmacother 1985;39:192-5.
26. Jacobs DR Jr, Muldoon MF, Råstam L. Low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: a search for causes and confounders. Am J Epidemiol 1995;141:518-22.
27. Feingold KR, Funk JL, Moser AH, et al. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun 1995;63:2041-6.
28. Ettinger WH, Harris T, Verdery RB, et al. Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc 1995;43:264-6.
29. Harris HW, Grunfeld C, Feingold KR, et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696-702.
30. Harris HW, Grunfeld C, Feingold KR, et al. Chylomicrons alter the fate of endotoxins, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993;91:1028-34.
31. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992;41(suppl 2):97-101.
32. Luepker RV, Murray DM, Jacobs DR, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health 1994;84:1383-93.
33. Jacobs DR, Anderson JT, Hannan P, et al. Variability in individual serum cholesterol response to change in diet. Arteriosclerosis 1983;3:349-56.